Core Competencies for Gerontogeriatric Nursing: A Validation Study.

Autor: Catalão MJ; Department of Health Sciences and Technologies, School of Health, Portalegre Polytechnic University, Campus Politécnico 10, 7300-555 Portalegre, Portugal.; CARE-Research Center on Health and Social Sciences, Portalegre Polytechnic University, 7300-555 Portalegre, Portugal.; Department of Education and Psychology, University of Aveiro, 3810-198 Aveiro, Portugal.; ICBAS, University of Porto, 4050-313 Porto, Portugal., Arco H; Department of Health Sciences and Technologies, School of Health, Portalegre Polytechnic University, Campus Politécnico 10, 7300-555 Portalegre, Portugal.; CARE-Research Center on Health and Social Sciences, Portalegre Polytechnic University, 7300-555 Portalegre, Portugal., Carrajola N; Department of Health Sciences and Technologies, School of Health, Portalegre Polytechnic University, Campus Politécnico 10, 7300-555 Portalegre, Portugal.; Department of Education and Psychology, University of Aveiro, 3810-198 Aveiro, Portugal.; ICBAS, University of Porto, 4050-313 Porto, Portugal., Almeida ML; Health Sciences Research Unit: Nursing-UICISA, Nursing School of Coimbra, 3046-851 Coimbra, Portugal., Neves H; Health Sciences Research Unit: Nursing-UICISA, Nursing School of Coimbra, 3046-851 Coimbra, Portugal., Tavares J; CINTESIS@RISE, Health Sciences Research Unit: School of Health, School of Health Sciences, University of Aveiro, 3810-198 Aveiro, Portugal.

Publikováno v: Geriatrics (Basel, Switzerland) [Geriatrics (Basel)] 2024 May 31; Vol. 9 (3). Date of Electronic Publication: 2024 May 31.

Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis .

Autor: Mandal M; Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal., Pires D; Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.; Center for Interdisciplinary Research in Health, Católica Medical School, Universidade Católica Portuguesa, Estrada Octávio Pato, 2635-631 Rio de Mouro, Portugal., Catalão MJ; Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal., Azevedo-Pereira JM; Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal., Anes E; Host-Pathogen Interactions Unit, Research Institute for Medicines, iMed-ULisboa, Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.

Publikováno v: Microorganisms [Microorganisms] 2023 Jul 24; Vol. 11 (7). Date of Electronic Publication: 2023 Jul 24.

CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival.

Autor: Silveiro C; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Marques M; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Olivença F; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Pires D; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.; Universidade Católica Portuguesa, Católica Medical School, Centre for Interdisciplinary Research in Health, Lisbon, Portugal., Mortinho D; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Nunes A; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.; Faculty of Veterinary Medicine, Universidade Lusófona, Lisbon, Portugal., Pimentel M; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Anes E; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal., Catalão MJ; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Mar 15; Vol. 13, pp. 1089911. Date of Electronic Publication: 2023 Mar 15 (Print Publication: 2023).

Identification of drivers of mycobacterial resistance to peptidoglycan synthesis inhibitors.

Autor: Olivença F; Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal., Ferreira C; Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal., Nunes A; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.; Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal., Silveiro C; Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal., Pimentel M; Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal., Gomes JP; Genomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.; Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal., Catalão MJ; Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2022 Sep 06; Vol. 13, pp. 985871. Date of Electronic Publication: 2022 Sep 06 (Print Publication: 2022).

Encapsulation of the septal cell wall protects Streptococcus pneumoniae from its major peptidoglycan hydrolase and host defenses.

Autor: Figueiredo J; Laboratory of Bacterial Cell Surfaces and Pathogenesis, UCIBIO-Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade Nova de Lisboa, Monte da Caparica, Portugal.; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.; Associate Laboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, Monte da Caparica, Portugal., Henriques MX; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal., Catalão MJ; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.; Host-Pathogen Interaction Unit, Faculty of Pharmacy, Research Institute for Medicines, iMed-ULisboa, Universidade de Lisboa, Lisboa, Portugal., Pinheiro S; Laboratory of Bacterial Cell Surfaces and Pathogenesis, UCIBIO-Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade Nova de Lisboa, Monte da Caparica, Portugal.; Associate Laboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, Monte da Caparica, Portugal., Narciso AR; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal., Mesquita F; Group of Molecular Microbiology, Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal., Saraiva BM; Laboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal., Carido M; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal., Cabanes D; Group of Molecular Microbiology, Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal., Pinho MG; Laboratory of Bacterial Cell Biology, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal., Filipe SR; Laboratory of Bacterial Cell Surfaces and Pathogenesis, UCIBIO-Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade Nova de Lisboa, Monte da Caparica, Portugal.; Laboratory of Bacterial Cell Surfaces and Pathogenesis, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.; Associate Laboratory i4HB-Institute for Health and Bioeconomy, School of Science and Technology, NOVA University Lisbon, Monte da Caparica, Portugal.

Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Jun 22; Vol. 18 (6), pp. e1010516. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).